Zhejiang Tianyu Pharmaceutical

Manufacturer

Audited

Audit report available

Warning letter

Headquarters

People's Republic of China

Sites

People's Republic of China

Issue date

17 Aug 2022

Issuing office

Center for Drug Evaluation and Research | CDER

Posted date

27 Sept 2022

Subject

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

Products & Services

Drugs